535 related articles for article (PubMed ID: 22415612)
1. Challenges in development of targeted liposomal therapeutics.
Sawant RR; Torchilin VP
AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
[TBL] [Abstract][Full Text] [Related]
2. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
3. Immunoconjugates and long circulating systems: origins, current state of the art and future directions.
Koshkaryev A; Sawant R; Deshpande M; Torchilin V
Adv Drug Deliv Rev; 2013 Jan; 65(1):24-35. PubMed ID: 22964425
[TBL] [Abstract][Full Text] [Related]
4. New Developments in Liposomal Drug Delivery.
Pattni BS; Chupin VV; Torchilin VP
Chem Rev; 2015 Oct; 115(19):10938-66. PubMed ID: 26010257
[No Abstract] [Full Text] [Related]
5. Passive and active drug targeting: drug delivery to tumors as an example.
Torchilin VP
Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
[TBL] [Abstract][Full Text] [Related]
6. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
Almeida B; Nag OK; Rogers KE; Delehanty JB
Molecules; 2020 Dec; 25(23):. PubMed ID: 33271886
[TBL] [Abstract][Full Text] [Related]
7. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
8. Liposheres as a Novel Carrier for Lipid Based Drug Delivery: Current and Future Directions.
Swain S; Beg S; Babu SM
Recent Pat Drug Deliv Formul; 2016; 10(1):59-71. PubMed ID: 26423443
[TBL] [Abstract][Full Text] [Related]
9. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
Oku N
Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Antibody-modified liposomes for cancer chemotherapy.
Torchilin V
Expert Opin Drug Deliv; 2008 Sep; 5(9):1003-25. PubMed ID: 18754750
[TBL] [Abstract][Full Text] [Related]
12. Liposomes: a novel topical delivery system for pharmaceutical and cosmetic applications.
Weiner N; Lieb L; Niemiec S; Ramachandran C; Hu Z; Egbaria K
J Drug Target; 1994; 2(5):405-10. PubMed ID: 7704485
[TBL] [Abstract][Full Text] [Related]
13. [Biological properties of liposomes and their practical application].
Halyts'ka SM; Nikol's'kyĭ IS
Fiziol Zh (1994); 2008; 54(5):99-108. PubMed ID: 19058519
[TBL] [Abstract][Full Text] [Related]
14. Immunoliposomes.
Paszko E; Senge MO
Curr Med Chem; 2012; 19(31):5239-77. PubMed ID: 22934774
[TBL] [Abstract][Full Text] [Related]
15. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
16. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
17. [Recent development of targeted drug delivery system].
Zhou PJ; Deng SQ; Gong QF
Yao Xue Xue Bao; 2010 Mar; 45(3):300-6. PubMed ID: 21351504
[TBL] [Abstract][Full Text] [Related]
18. Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform.
Saraf S; Jain A; Hurkat P; Jain SK
Crit Rev Ther Drug Carrier Syst; 2016; 33(5):401-432. PubMed ID: 27910741
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
Raimondo S; Giavaresi G; Lorico A; Alessandro R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
[TBL] [Abstract][Full Text] [Related]
20. Molecular targeting of liposomal nanoparticles to tumor microenvironment.
Zhao G; Rodriguez BL
Int J Nanomedicine; 2013; 8():61-71. PubMed ID: 23293520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
